Careers

Contact

logo
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • HSCA Connect
  • Events
    • 2023 National Pharmacy Forum
    • Past Events
  • Issues
  • Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • Small Supplier Portal
    • Congressional Resources
    • COVID-19 Recommendations
    • COVID-19 Response Efforts
  • News
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • HSCA Connect
  • Events
    • 2023 National Pharmacy Forum
    • Past Events
  • Issues
  • Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • Small Supplier Portal
    • Congressional Resources
    • COVID-19 Recommendations
    • COVID-19 Response Efforts
  • News

Comments of the Healthcare Supply Chain Association to FDA on Identifying the Root Causes of Drug Shortages and Finding Enduring Solutions

January 11, 2019 by admin 2019 Press Releases 0 comments

On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments to the U.S. Food and Drug Administration (FDA) on the causes of critical prescription drug shortages and potential solutions.

HSCA, its member GPOs, and our member healthcare providers are committed to preventing and mitigating prescription drug shortages and ensuring continued patient access to essential medications. We applaud the FDA for having taken steps to address drug shortages, including forming a drug shortage task force. As FDA has previously noted, drug shortages are a complex issue caused by quality problems, manufacturing delays, and capacity difficulties and one that requires a multi-stakeholder solution. A 2018 study conducted by Alex Brill at Global Matrix Advisors echoed FDA’s findings on drug shortages and also emphasized the need for a multi-stakeholder solution. In pursuit of finding a multi-stakeholder solution, HSCA participates in a drug shortage working group composed of leading healthcare provider organizations – including hospitals, health-system pharmacists, physicians, GPOs, and other supply chain stakeholders – to develop policy proposals to help prevent and address drug shortages in a comprehensive manner. A number of those policy ideas are reflected in HSCA’s recommendations below.

Read the full comments…

Prev
Next

Related Posts

Comments of the Healthcare Supply Chain Association to FDA on Identifying the Root Causes of Drug Shortages and Finding Enduring Solutions
January 11, 2019

On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...

Learn more
HSCA Announces 2019 Board of Directors and Names GNYHA Ventures President Lee Perlman Board Chair
January 24, 2019

Washington, DC (January, 2019) – The Healthcare Supply Chain Association (HSCA)...

Learn more
HSCA Names Leading National Healthcare Expert Khatereh Calleja as President & CEO
April 2, 2019

Washington, DC (April 2, 2019) – The Healthcare Supply Chain Association (HSCA)...

Learn more
HSCA E&C Letter on Improving Competition in the Generic Marketplace
April 1, 2019

Dear Chairman Pallone and Ranking Member Walden, I am writing to you on behalf...

Learn more

Our Office

Healthcare Supply Chain Association
1341 G Street NW Suite 600
Washington, DC 20005

Phone: 202.629.5833
Fax: 202.466.9666
Email: info@supplychainassociation.org

LATEST NEWS

  • Job Posting: HSCA Program Associate
    January 5, 2023
  • HEALTHCARE SUPPLY CHAIN ASSOCIATION JOINS END DRUG SHORTAGE ALLIANCE TO SAFEGUARD ACCESS TO ESSENTIAL MEDICATIONS
    October 12, 2022